-
H ow I treat…. psoriasis comorbidities by the adalimumab (Humira®) anti-TNF α biological
Piérard-Franchimont C. , Henry F. , Szepetiuk G. , Piérard G.E.
Rev Med Liege 2010, 65(10),545-548Abstract : SUMMARMMARMMARMMARY : Psoriasis is primarily a chronic inflammatory skin disease burdened by some comorbidities including psoriatic alopecia, arthropathies, Crohn’s disease, the metabolic syndrome and some cardiovascular involvement. During the past years, several biologicals corresponding to monoclonal antibodies were offered to treat psoriasis refractory to other potent conventional treatments. We review the effects of biologicals, in particular adalimumab (Humira®), on psoriatic comorbidities.
